Company profile
Hearing Diagnostics Limited
Hearing Diagnostics Limited Changing the way the world tests for hearing loss
Accurate, cost-efficient hearing tests without a hospital. Cost-efficient, modern hearing testing purpose-built for healthcare providers, hearing aid retailers, and local communities. Get involved Request demo About Us Meet AUDIMETROID The future of hearing testing belongs to communities, not hospitals. Hearing Diagnostics makes it possible for community healthcare providers to offer accurate and cost-efficient hearing testing
Latest accounts
Financial period: 1 Oct 2023 to 30 Sep 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQzNDExODY4MGFkaXF6a2N4
Published 02 Sep 2024 09:24
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Audimetroid, a tool for rapid delivery of hearing care and hearing aids
1 Jun 2020 to 28 Feb 2021
Social isolation during lockdown is putting 15.5 million elderly individuals at increased risk of premature frailty due to fostering mental health deterioration (Armitage 2020). It is absolutely crucial that elderly individuals have ready access to audiology services so they have the strongest possible opportunity of rapidly returning to a socially-active...
Audimetroid, a new hearing screening technology
1 Feb 2018 to 31 Aug 2018
Hearing loss affects 360 million people worldwide and 11 million people within the UK, with most of those affected being 65 years of age, or older. Un-managed hearing loss in the elderly commonly leads to social isolation and depression, and may cause or accelerate the progression of cognitive decline and dementia. Management is thus crucial, and is most ...